168 related articles for article (PubMed ID: 20609213)
1. A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha.
Kuroishi A; Bozek K; Shioda T; Nakayama EE
Retrovirology; 2010 Jul; 7():58. PubMed ID: 20609213
[TBL] [Abstract][Full Text] [Related]
2. Slower uncoating is associated with impaired replicative capability of simian-tropic HIV-1.
Kono K; Takeda E; Tsutsui H; Kuroishi A; Hulme AE; Hope TJ; Nakayama EE; Shioda T
PLoS One; 2013; 8(8):e72531. PubMed ID: 23967315
[TBL] [Abstract][Full Text] [Related]
3. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells.
Kuroishi A; Saito A; Shingai Y; Shioda T; Nomaguchi M; Adachi A; Akari H; Nakayama EE
Retrovirology; 2009 Aug; 6():70. PubMed ID: 19650891
[TBL] [Abstract][Full Text] [Related]
4. Anti-retroviral activity of TRIM5 alpha.
Nakayama EE; Shioda T
Rev Med Virol; 2010 Mar; 20(2):77-92. PubMed ID: 20049904
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α.
Miyamoto T; Yokoyama M; Kono K; Shioda T; Sato H; Nakayama EE
PLoS One; 2011; 6(7):e22779. PubMed ID: 21829511
[TBL] [Abstract][Full Text] [Related]
6. Novel mutant human immunodeficiency virus type 1 strains with high degree of resistance to cynomolgus macaque TRIMCyp generated by random mutagenesis.
Sultana T; Nakayama EE; Tobita S; Yokoyama M; Seki Y; Saito A; Nomaguchi M; Adachi A; Akari H; Sato H; Shioda T
J Gen Virol; 2016 Apr; 97(4):963-976. PubMed ID: 26795727
[TBL] [Abstract][Full Text] [Related]
7. Impact of TRIM5α in vivo.
Nakayama EE; Shioda T
AIDS; 2015 Sep; 29(14):1733-43. PubMed ID: 26372380
[TBL] [Abstract][Full Text] [Related]
8. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
9. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.
Kono K; Song H; Yokoyama M; Sato H; Shioda T; Nakayama EE
Retrovirology; 2010 Sep; 7():72. PubMed ID: 20825647
[TBL] [Abstract][Full Text] [Related]
10. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.
Lin TY; Emerman M
Virology; 2008 Sep; 379(2):335-41. PubMed ID: 18678385
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5alpha.
Ridolfi B; Catone S; Sgarbanti M; Sernicola L; Battistini A; Parolin C; Titti F; Borsetti A
J Cell Physiol; 2009 Dec; 221(3):760-5. PubMed ID: 19746418
[TBL] [Abstract][Full Text] [Related]
12. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA.
Yang R; Aiken C
J Virol; 2007 Apr; 81(8):3749-56. PubMed ID: 17267487
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.
Song H; Nakayama EE; Yokoyama M; Sato H; Levy JA; Shioda T
J Virol; 2007 Jul; 81(13):7280-5. PubMed ID: 17475650
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus restriction by TRIM5 proteins requires recognition of only a small fraction of viral capsid subunits.
Shi J; Friedman DB; Aiken C
J Virol; 2013 Aug; 87(16):9271-8. PubMed ID: 23785198
[TBL] [Abstract][Full Text] [Related]
15. Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T Cells.
Jimenez-Moyano E; Ruiz A; Kløverpris HN; Rodriguez-Plata MT; Peña R; Blondeau C; Selwood DL; Izquierdo-Useros N; Moris A; Clotet B; Goulder P; Towers GJ; Prado JG
J Virol; 2016 Oct; 90(19):8552-62. PubMed ID: 27440884
[TBL] [Abstract][Full Text] [Related]
16. TRIM5α and Species Tropism of HIV/SIV.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():13. PubMed ID: 22291694
[TBL] [Abstract][Full Text] [Related]
17. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
18. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
Kamada K; Igarashi T; Martin MA; Khamsri B; Hatcho K; Yamashita T; Fujita M; Uchiyama T; Adachi A
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16959-64. PubMed ID: 17065315
[TBL] [Abstract][Full Text] [Related]
19. Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.
Shi J; Aiken C
Virology; 2006 Jul; 350(2):493-500. PubMed ID: 16624363
[TBL] [Abstract][Full Text] [Related]
20. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.
Grütter MG; Luban J
Curr Opin Virol; 2012 Apr; 2(2):142-50. PubMed ID: 22482711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
